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Abstract
RNA-seq has become a de facto standard for measuring gene expression. Traditionally, RNA-seq exper-
iments are mathematically averaged – they sequence the mRNA of individuals from different treatment
groups, hoping to correlate phenotype with differences in arithmetic read count averages at shared loci of
interest. Alternatively, the tissue from the same (or more) individuals may be pooled prior to sequencing
in what we refer to as a biologically averaged design. As mathematical averaging sequences all individuals
it controls for both biological and technical variation; however, is the statistical resolution gained always
worth the additional cost? To compare biological and mathematical averaging, we examined theoretical
and empirical estimates of statistical efficiency and relative cost efficiency. Though less efficient at a fixed
sample size, we found that biological averaging can be more cost efficient than mathematical averaging,
especially if biological variation is large and biologically averaged individuals can be pooled evenly. With
this motivation, we developed a differential expression classifier, ICRBC, that can detect alternatively
expressed genes between biologically averaged samples. In simulation studies, we found that biological
averaging and subsequent analysis with our classifier performed comparably to existing methods, such
as ASC, edgeR, and DESeq, especially when individuals were pooled evenly and less than 20% of the
regulome was expected to be differentially regulated. In two technically distinct mouse datasets and one
plant dataset, we found that our method was over 87% concordant with edgeR for the 100 most significant
features. While biological averaging cannot provide the same statistical resolution as a well replicated
mathematically averaged experiment, it may sufficiently control biological variation to a level that differ-
ences in gene expression may be detectable. In such situations, ICRBC can enable reliable exploratory
analysis at a fraction of the cost, especially when interest lies in the most differentially expressed loci.
Introduction
RNA-Seq [1] is a popular alternative to microarray based methods for measuring gene expression [2].
RNA-seq quantitatively measures gene expression as counts, and typically involves isolating a subject’s
mRNA, converting to cDNA, and sequencing. Sequencing reads are then computationally “mapped” to
loci of interest (e.g. genes or exons), and the number of reads associated with each loci is stored in a
p-loci by n-individuals matrix [1,3]. Matrices built from individuals representing phenotypically different
populations may then be compared in order to correlate differences in gene expression with phenotype.
Most current methods for detecting differential expression utilize the mathematical average of a gene’s
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2read counts across sequenced samples from the same population as a point estimate for its expression [4–8].
We refer to these traditional designs, in which each individual’s mRNA is sequenced, as mathematically
averaged experiments. Because multiple samples are sequenced, mathematical averaging allows the re-
searcher to control for not only biological variation, but also technical variation that arises from the
measurement process [9]. While technical variation is typically too large to ignore [10], biological varia-
tion is typically more pronounced [11].
In contrast, one may also consider designs in which tissue from each individual is pooled prior to mRNA
isolation and sequencing. Since the pool represents an average of biological samples, we refer to these
designs as biologically averaged experiments. Biological averaging has received considerable attention in
the microarray community [12–14], where it’s believed most effective when 1) biological variation exceeds
technical variation and 2) many individuals can be pooled. In fact, Zhang (2007) [14] show even when
biological and technical variation are equal in magnitude, arraying ten pools of ten individuals each affords
90% of the statistical power at 10% of the cost of a study that arrays every individual. Surprisingly, there
has been little statistical treatment of biological averaging the RNA-Seq literature. Due to sequencing
costs and experimental scale, several studies applied RNA-Seq to pooled [15–17] or unreplicated [18–20]
samples, but employed statistical tests (e.g. Fisher’s exact test [9]) and methods (e.g. DEGSeq [7]) that
only adequately model technical variability.
It’s clear that both mathematical and biological averaging control for subject-to-subject variability
and makes population level differences easier to detect [9]; however, what are the statistical and monetary
trade-offs associated with each design? By what metric can we suggest one design is “better” than the
other? How do the number of individuals enrolled and pooling evenness affect the quality of biologically
averaged gene expression estimates? To our knowledge, the empirical bayes routine, ASC, is the only
method that is capabable of analyzing biologically averaged experiments [21]; however, the authors of
this method do not provide a statistical justification of biological averaging.
In this work, we consider the relative efficiency [22] of biological and mathematical averaging in
estimating intrapopulation level expression levels. Additionally, we examine a modified objective – the
relative cost efficiency – which also considers experimental cost. We show on three biologically and
technically varied datasets [23–25] that biological averaging can be statistically more cost efficient than
mathematical averaging, and that it may be particularly useful for exploratory analysis if interpopulation
similarity is high, multiple individuals are enrolled, and individuals are pooled relatively evenly. For
such scenarios, we present an iterative confidence-region based classifier (ICRBC) to detect differentially
expressed genes in biologically averaged experiments. We provide results from two simulation experiments
and real data to show our classifier provides reasonable results, especially when interest lies in the most
significant loci.
Statistical concerns
For any significance test, a random variable’s expected value and variance under an assumed null dis-
tribution are required. In this section, we consider statistical practicalities of estimating the expected
value and variance of a gene’s population level expression under mathematically and biologically averaged
designs. We consider their relative cost efficiency – a measure of statistical power gained per dollar – and
provide a motivating example from real data that suggests the potential utility of biological averaging.
Preliminaries
Figure 1A illustrates a typical workflow for a mathematically averaged design, in which mRNA is isolated,
converted to cDNA, and sequenced for each of n individuals [9]. Thereafter, sequencing reads are mapped
to loci of interest and the final output is a p-loci by n-individuals count matrix, O. The entry, Oij ∈ N0,
of this count table, denotes the number of reads that map to loci i in individual j. Figure 1B depicts a
3biologically averaged design in which tissue from each individual is instead pooled into a single sample
prior to mRNA isolation and sequencing. The proportional representation of the ith individual in the
pool is denoted by ai ∈ [0, 1]. We assume that individuals are independent and identically distributed
(IID) with respect to their expression profiles.
Assuming the measurement process (mRNA isolation, conversion to cDNA, sequencing, and the com-
putational mapping of reads) is independent of all individuals, the total variance in read count at a
particular locus is the sum of biological and technical variance [5]. Biological variation, denoted by
σ2B(g), is the natural variation in expression level for gene g found among individuals in a given popula-
tion. Technical variation, given by σ2T (g), is the additional variation in the estimated expression level of
gene g introduced by the measurement process.
Relative Cost Efficiency
Theory
The relative efficiency between two estimators or measurement procedures is given by the ratio of their
variances [22]. If the variance of one procedure is larger than the other for a fixed sample size, n, then
the procedure is less efficient and necessarily requires more data to detect differential expression at a
prespecified level of confidence (i.e. it has a lower signal-to-noise ratio).
Let dm(g,O) =
1
n
∑n
i=1Ogi denote the point estimate of gene g’s expression from a mathematically
averaged experiment, and let db(g,O) = Og denote the biologically averaged estimate. The relative
efficiency of these estimators is given by (see derivation in Section 1 of SI):
effrel(db, dm) =
V[db(g,O)]
V[dm(g,O)]
=
σ2T (g) + σ
2
B(g)
1
n (σ
2
T (g) + σ
2
B(g))
> 1.
Here  is a measure of pooling evenness and is bounded between 1/n and 1.
Notice that effrel is always greater than 1, implying that a biologically averaged experiment is less
efficient for fixed n. This is expected because a biologically averaged design cannot control for technical
variation through replication of the sequencing process. However, it may be useful to also consider the
relative cost efficiency, effrc, which proportionally penalizes the relative efficiency by experimental cost.
If we let q denote the cost of obtaining a tissue sample from an individual, and s the cost of preparing
and sequencing a single library, then the relative cost efficiency is given by (see derivation in Section 2 of
SI),
effrc(n|db, dm) = cost(db)
cost(dm)
× V[db(g,O)]
V[dm(g,O)]
=
nq + s
q + s
× σ
2
T (g) + σ
2
B(g)
σ2T (g) + σ
2
B(g)
Intuitively, this objective favors the method that best manages the trade off between experimental cost
and estimation precision. Like before, a value for effrc > 1 suggests mathematical averaging is a more
desirable design; however, because experimental cost is also considered, this objective quite literally
quantifies “bang for the buck.”
Note that previous derivations for effrc are invariant with respect to any distributional assumptions
about read counts. If we now make the standard assumption that read counts follow a Negative-Binomial(µ, α)
4distribution [4, 5], then under the NB2 parameterization, σ2T (g) = µ and σ
2
B(g) = αµ
2, where µ and α
denote gene g’s expected expression level and the dispersion parameter, respectively [5]. Thus,
effrc(n, µ|db, dm) = nq + s
q + s
× µ+ αµ
2
µ+ αµ
Finally, instead of conditioning only on the expression level of a single gene, we may average over all
expression levels by considering the expected relative cost efficiency (ERCE),
E[effrc(n, µ|db, dm)] =
(
nq + s
q + s
)
×∫
µ∈R+
µ+ αµ2
µ+ αµ2
f(µ) dµ
were f(·) is a probability density function.
Pooling evenness
In the efficiency expressions above,  =
∑n
i=1 a
2
i , and is a measure of how evenly samples are pooled
in a biologically averaged design. It is uniquely minimized when ai = 1/n ∀i (a perfectly even pool),
and uniquely maximized when ai = 1 and aj = 0 ∀j 6=i (a perfectly uneven pool – only one individual is
effectively included).
When among n individuals only a single individual’s tissue is included in the pool ( = 1), the integral
in the expression for the ERCE evaluates to unity. In this case, the expected relative cost efficiency grows
linearly in n, and remains greater than 1, suggesting that mathematical averaging is the better design.
This is intuitively reasonable because a stable (low-variance) estimate of a gene’s expression is difficult
to obtain with a single individual.
By contrast, consider when all n individuals are equally represented in the pool ( = 1/n). In this
case, the relationship between the expected relative cost efficiency and n is non-trivial. It is easily
shown that when  = 1/n, effrc(n, µ|db, dm) is concave for all n > 1, and uniquely minimized by n∗ =
(σB(g)/σT (g))
√
s/q; however whether the ERCE is less than 1 (biological averaging is more cost effective)
will depend on the relative magnitudes of not only tissue isolation and sequencing costs, but also technical
and biological variation. Additionally, as we will see, pooling evenness plays an influential role.
Empirical motivation
Because experimental costs, pooling evenness, and the magnitudes of technical and biological variation
depend on experimental design and organism, definite trends in the ERCE (i.e. whether it is above or
below 1) are not readily abstractable. Moreover, the ERCE is ultimately a function of n, the number of
individuals to be included in an RNA-seq experiment. Given that effrel is concave in n, the ERCE will
also be concave in n, but does it ever go below 1? If so, for what n? Most importantly, what are the
practical implications of its behavior?
To answer these questions we looked at three RNA-Seq datasets from two technically distinct mouse
experiments [23,25] and one plant experiment [24]. Because these datasets are used frequently hereafter,
we introduce each below and mention their relevance to this work. We refer to each dataset by the last
name of the first author.
Dataset description
Cumbie – Cumbie et al. developed the fully integrated computational pipeline GENECounter for the
analysis of RNA-Seq data [24]. To test their package, they inoculated the leaves of Arabidopsis thaliana
5plants with either MgCl2 (control) or an avirulent ∆hrcC mutant strain in order to assess whether their
analysis pipeline could detect differentially expressed genes known to be involved in the well studied
plant Hypersensitive Response (HR) to avirulent pathogens [26]. Their dataset consists of three wildtype
and three mutant biological replicates, and provides an organismal contrast to the two mouse datasets
detailed below.
Katz – Katz et al. developed MISO, a statistical model designed to detect differential isoform
expression [23]. In addition to investigating the possible roles of the splicing factor hnRNP H in isoform
regulation and alternative polyadenylation, they examined the effects of read pairing and library insert
length on MISO’s ability to identify differentially regulated isoforms between normal mouse myoblasts
and myoblasts depleted of the splicing factor CUGBP1. Their data consists of two biological replicates of
normal myoblasts and two biological replicates of CUGBP1 depleted myoblasts. Because each biological
replicate within each population was prepared with a different insert length, this dataset is technically
more varied than the Cumbie and Bottomly datasets.
Bottomly – Bottomly et al. compared the concordance between RNA-Seq and two microarray plat-
forms in detecting differential striatal gene expression between C57BL/6J (B6) and DBA/2J (D2), two
commonly used inbred mouse strains in neuroscience research [25]. Their dataset consists of 10 B6 and
11 D2 striatal tissue samples. Their large sample size enables us to compare the marginal benefit of
sequencing many samples to sequencing only a single, biologically averaged sample.
Expected relative cost efficiency curves
Using edgeR, we obtained a boostrapped estimate, αˆ, of each dataset’s dispersion parameter. Using
each study’s method description, we additionaly estimated the cost of tissue isolation, q, and the cost of
sample preparation and sequencing to each study’s median depth, s. Table 1 summarizes these estimates
(see Section 2.2 in the SI for a derivation of our estimates). Using the median count profile of all control
(e.g. wildtype) samples as an exemplar for the “typical” individual, we examined how nonparametric
estimates of the ERCE would behave for each study if more hypothetical individuals, similar to the
exemplar, were enrolled. Section 2.1 in the Supplementary Information provides a complete description
of this nonparametric fitting procedure.
Figure 2 illustrates our empirical estimates of the ERCE as a function of the number of hypothetical
individuals enrolled. Because the ERCE is sensitive to how evenly individuals are pooled during biological
averaging, we considered three pooling types: 1) perfectly even ( = 1/n), 2) perfectly uneven ( = 1),
and 3) randomly generated uniformly uneven pools, designed to represent human error in pooling a
biologically averaged library (see Figure 2 in SI).
As expected, when pooling is completely uneven, mathematical averaging handily outperforms bio-
logical averaging. On the other hand, the ERCE for a perfectly even pool remains below 1 for 2 ≤ n ≤ 20
for all three datasets, and illustrates the idealized case of zero pooling error in a biologically averaged
design.
Surprisingly, the ERCE trend is much the same for uniformly uneven pools. There is considerable
variability in the ERCE when only a few individuals are pooled under this scheme; however, this variance
stabilizes quickly and shortly after the minimum ERCE, which seems to occur typically between 3 and
10 individuals.
Interestingly, the uptrend in the ERCE for Cumbie is attenuated relative to the uptrends for Katz
and Bottomly. The slower rise for Cumbie is partially attributable to the increased cost of sequencing
individuals to a depth of 5 million reads. However, further sensitivity analyses via permutation test of
the dispersion and cost estimate effects on the ERCE revealed that the most influential factor was the
higher biological dispersion, which is roughly two-fold greater in the Cumbie data set. In theory, this is
likely attributable to the difference in organism (plant versus mouse).
Taken together, these results suggest that biological averaging can provide a 1.3-2.2 fold signal-to-noise
increase per dollar, thus motivating its potential use as an experimental design especially in experimental
6systems with large biological variation.
Methods
While it may be a more cost efficient solution in some cases, biological averaging presents unique challenges
for differential expression expression analysis. Biological averaging may be combined with mathematical
averaging by sequencing multiple pools of individuals. However, in this work we assume individuals
from the same population are averaged into a single pool. Because there is only sequenced replicate per
condition, independent variance estimates at each locus cannot be readily obtained. However, if biological
variance is larger than technical variance [11] and a minority of genes are expected to be induced by a
population condition [27], variance estimates can be obtained by pooling information across loci [4,5,21].
We now an iterative confidence region based classifier (ICRBC) that is capable of differential expression
analysis in biologically averaged experiments.
Modeling
The Negative-Binomial distribution has been commonly applied to RNA-seq data as an overdispersed
Poisson model [4, 5, 24]. Most frequently the NB2 parameterization is employed, in which E[Og] = µ
and V[Og] = µ + αµ
2 [28]. The parameter, α, is known as the dispersion parameter, and it signifies
the amount of intrapopulation biological variation. Setting it equal to 0 recovers the original Poisson
model [28].
In this work, we assume intrapopulation read counts follow a NB2 parameterized, Negative-Binomial(µ, α)
distribution. Let O:,1 and O:,2 denote the observed read count vectors of two sequenced samples repre-
senting two different populations in a biologically averaged experiment. Let M = log2(O:,2)− log2(O:,1)
and A = (log2(O:,2) + log2(O:,1))/2. This transformation is known as the MA-trasformation [29].
Using delta method [30], it can be shown that log2(Oi,j) is approximately normally distributed given
gene i is not differentially expressed. Using this approximation, we show in Section 3 of the Supplemental
Information that M|A=a ∼ Normal(θ, g(a)), where g(·) is a continuous and smooth function of a. Note
that while θ is invariant with respect to a, the variance of M with respect to A is not. The level mean
and overall heteroscedasticity as functions of A can be visually seen in Figure 3, where two MA plots of
two different sample pairings from the Cumbie dataset have been overlaid.
Iterative Confidence Region Based Classification (ICRBC)
Figure 3 shows overlayed MA plots made from a control/control sample pairing (blue data points), where
all genes are expected to follow a null distribution, and a control/∆hrcC sample pairing, (red data
points), where some genes may be differentially expressed. Near the superior edge of the point cloud
(more positive M), there are red data points that extend vertically beyond the mass of blue data points,
implying these red points may represent differentially expressed genes. In other words, these genes appear
as “outliers” when compared to the larger mass of regularly expressed features.
Algorithm 1: ICRBC
1. Input: O:,1, O:,2, κ
2. [a, m] = maTransform(O:,1, O:,2)
3. S = {i : |mi − median(m)| < 0.05× std(m)}
while S changing
(a) θˆ = mean(m(S))
7(b) gˆ(x) = loess
(
a(S),
[
m(S)− θˆ
]2)
(c) z =
(
m− θˆ
)
/
√
gˆ(a)
(d) S = {i : |zi| < t1−κ/2,n−2}
4. [p, q] = pqVals(m, a, gˆ(x), θˆ)
5. Return: S, q, p
Algorithm 1 details an Iterative Confidence Region Based Classifier (ICRBC), which detects differ-
entially expressed genes (the “outliers”) from MA-transformed count data. During initialization, two
input count vectors from two biological averaged experiments are MA-transformed, and a set of indices,
S, is chosen to be indices of those loci with m-coordinates that slightly deviate from the median of all
m-coordinates. While the elements of S continue to change, the algorithm iteratively alternates between
estimating parameters of the null model – g(a) and θ – and estimating the index set of loci participating
in the null model, S.
Specifically, an estimate of θ is obtained by the sample mean of m-coordinates belonging to loci
currently estimated to be null. The variance function, g(a) is estimated by performing local regression of
the squared null m-coordinate residuals onto the null a-coordinates. This effectively pools information
across loci with similar expression levels, and in so doing, provides an unbiased estimate of the conditional
m-coordinate variance. The local regression is done using weighted linear least squares and a 2nd degree
polynomial model [31]. Subsequently, all m-coordinates are z-transformed (standardized), and the indices
of those standardized coordinates that lie within (κ/2, 1−κ/2)-percentiles of the t-distribution are set as
the indices of null features. The t-distribution is used here because the standardizing mean and variance
are estimated quantities. Throughout this work we use κ = 0.01.
The procedure concludes with significance testing of each loci using the final estimates of θ and g(a).
Feature p-values are calculated with respect to tail probabilities of the t-distribution, and q-values are
obtained using the method of [32].
At its core, the ICRBC algorithm is simply a series of sequential hypothesis tests that serve as filters
that let pass the loci that do not appear too extreme given a current null set, and screen out the loci that
do. Alternatively, if the null index set S is considered as auxillary or missing-data, then Algorithm 5 can
be seen as an approximate hard-EM algorithm [33], where the E-step involves estimating S given θ and
g(a), and the M-step involves estimating θ and g(a) given S. The approximation arises from estimating
g(a) nonparametrically, as opposed to maximizing the expected log-likelihood function with respect to
the conditional distribution of S.
Results
Baseline Comparisons
Throughout this section, we compare ICRBC to edgeR [4], DESeq [5], and ASC [21]. The edgeR and
DESeq models are both based on the Negative Binomial distribution, require at least two biological
replicates, and pool information across loci of similar expression values in order to estimate the dispersion
parameter. In a recent survey of eleven differential expression detection algorithms, the authors of [34]
found that edgeR and DESeq most often performed the best and noted that edgeR tended to be more
liberal in calling differential expression, whereas DESeq was more conservative.
The Analysis of Sequence Counts (ASC) is an empirical Bayes method for detecting differential ex-
pression in biologically averaged experiments. Like ICRBC, ASC estimates the expected null variation
in expression levels between two samples by conditioning on average expression. However, instead of
8estimating this relationship nonparametrically as ICRBC does, ASC assumes in its prior that log10RPM
expression values across loci follow a shifted exponential distribution.
Simulation Studies
Biological versus Mathematical Averaging
In this experiment, we explore how ICRBC and the baseline methods perform in simulated mathematically
and biologically averaged samples in order to assess how ICRBC performs as a function of 1) the number
of individuals and 2) pooling evenness. Additionally, we directly compare how ICRBC’s differential
detection rates on biologically averaged samples compare to edgeR, which uses all available sequenced
replicates.
Data generation – The three control (MgCl2) count vectors from the Cumbie dataset were mathe-
matically averaged, gene-by-gene, and set to be the ‘normal’ population level expression vector, µ. A total
of p = 33672 loci had non-zero expression levels after averaging. To simulate ‘normal’ tissue samples,
each of 10 p-long Gamma(α, 1/α) random vectors (parameterized by shape and scale, respectively) were
first multiplied element-wise with µ thereby producing 10 transcript vectors with mean µ and variance
αµ2 [28]. Transcript vectors represent transcript abundances in a tissue sample, and not read counts ob-
tained after sequencing – variability is entirely attributable to biological variation (αµ2). The dispersion
parameter, α was set to be 0.03.
Ten ‘abnormal’ tissue samples were simulated by first randomly selecting 12.4% (4160) of the 33672
genes to be differentially expressed. Differential expression was simulated by altering µ to µ∗, where
selected loci (entries of µ) were modified the formula µ∗i = U[1.6,5]sign{U[0,1] − 0.3}
√
αµ2i . Here, U[a,b]
denotes a Uniform[a,b] random number. In words, approximately 70% of the genes chosen to be differ-
entially expressed were upregulated (the remaining were downregulated), and the degree of expression
difference was set to be 1.6 to 5 standard deviations away from the true expression value. Note that
the 1.6 to 5 standard deviation interval suggests considerable overlap between the null distribution and
the alternative, thus making the classification task non-trivial. Subsequently, 10 ‘abnormal’ transcript
vectors were generated by multiplying 10 p-long Gamma(α, 1/α) by µ∗. The dispersion parameter, α, for
‘abnormal’ individuals was also set to 0.03.
From the transcript vectors, we then proceeded to simulate the sequencing process to produce read
count vectors. To simulate a count table for a mathematically averaged design of n individuals (n ∈
{1, 2, . . . , 10}), each of the 20 transcript vectors (10 ‘normal’ and 10 ‘abnormal’) were first multinomially
sampled dU[2×106,4×106]e times to produce 20 read count vectors. The process of multinomial sampling
simulates the sequencing process by adding technical variance of magnitude µ [1,4,30]. Subsequently, for
each population n read count vectors were concatenated to produce a 33672× 2n count table.
To simulate a count table for a biologically averaged design of n individuals, n transcript vectors from
each population were averaged with either even weights (normal arithmetic average) or uneven weights.
This averaged transcript vector was then multinomially sampled dU[2×106,4×106]e times, to produce a
single read count vector for each population. Uneven averaging was done such that a single individual
always had an pooling weight greater than 0.4 (see Figure 3 in SI for exact pooling weights). This provides
for a substantially more uneven pool than is likely to occur in practice.
Results – Figure 4 illustrates the average performance of ICRBC, edgeR, and ASC on 20 independent
simulation replicates. DESeq’s performance is omitted here for clarity; in all cases DESeq’s curves closely
mimicked those of ICRBC-MA (red). ICRBC was run on not only the evenly (EBA, black) and unevenly
(UBA, blue) pooled samples, but also gene-by-gene arithmetic averages of the count tables produced
from the mathematically averaged experiment (MA, red). Curves for ASC illustrate it’s performance on
the evenly pooled biologically averaged (EBA) samples.
Figure 4A shows the performance of ASC and ICRBC on a single sample. Power is relatively low,
and around 2000 genes can be called differentially expressed at an expected 5% false discovery rate. For
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a single sample ICRBC detects 1844/4260 = 43.3% of differentially expressed genes while incurring five
false discoveries. ASC detects 1054/4260 = 24.7% of differentially expressed genes while incurring five
false discoveries.
Figure 4C depicts two sample performance. When ICRBC is run on the uneven biological average,
it performs slightly better than a single sample, detecting 1887/4260 = 44.3% of differentially expressed
genes while incurring five false discoveries. However, when tissue from both individuals is more evenly
shared in the pool, classification improves markedly such that 55.7% of differentially expressed genes are
correctly detected at the same FDR. In fact, when running ICRBC on evenly pooled data, classification
accuracy is comparable to edgeR, and interestingly to ICRBC’s performance on arithmetically averaged
count tables. However, edgeR consistently provides a lower true FDR. In contrast to ICRBC, ASC falls
intermediate in FDR estimates and classification accuracy to ICRBC’s uneven pool performance and
even pool performance, suggesting it is less efficient.
The right panel in 4C also shows that the ordering of loci by significance using ICRBC and ASC on
well pooled samples is 93%-96% concordant with edgeR for the top 2900 features. When considering
the top 4160 loci, only ICRBC’s significance ordering when run on mathematically averaged read count
vectors exceeds 90%, though ICRBC and ASC’s significance ordering when run on evenly pooled samples
is not far behind. ICRBC’s significance ordering when run on unevenly pooled samples shows considerable
disagreement with edgeR.
Five sample and ten sample performance trends (Figure 4C and 4D) are similar. ICRBC’s performance
on unevenly pooled samples lags behind, followed by ASC’s performance. On five evenly pooled samples
ICRBC classifies as well as edgeR, but is slightly outperformed when ten samples are available. However,
ICRBC’s classification accuracy on averaged read count vectors is not statistically different from that
of edgeR’s. Notice now that edgeR provides a substantially lower true FDR than all other ICRBC and
ASC runs. When ten samples are available edgeR detects 99.4% of differentially expressed features with
fewer than five false discoveries. ICRBC and ASC on evenly pooled samples detect 93.2% and 75.6% of
differentially expressed features, respectively, with five false discoveries. Because true FDR curves are
not observed in practice, it is worth noting that all methods consistently overestimate the FDR.
Breakdown
Both ASC and ICRBC assume that most loci are not affected by alternate conditions of interest, but what
is the practical limit of “most?” In this experiment, we examine at what percentage of truly differentially
expressed genes the assumptions of high interpopulation similarity breakdown.
Data generation – Read count vectors for this experiment was generated exactly as described for
the ‘Biological versus Mathematical Averaging’ experiment; however, instead of inducing a fixed number
of genes for ‘abnormal’ individuals, we induced between 0% and 50% at 20 evenly spaced intervals.
Results – Figure 4B illustrates the breakdown performance of edgeR, ICRBC, and ASC. ICRBC and
ASC were run on a single ‘normal’ and ‘abnormal’ sample each obtained by biologically averaging from
10 evenly pooled individuals. edgeR was run on 10 ‘normal’ and 10 ‘abnormal’ read count vectors.
Both ASC and ICRBC give accurate results when 0% to 20% of all loci are induced, though ICRBC
slightly outperforms ASC in classification accuracy. When more than 25% of all features are induced
ASC and ICRBC give less reliable results than those obtained using edgeR in a mathematically averaged
design.
Real Data
In order to better understand how ICRBC’s perfomance may compare to the other baseline methods in
practice, we ran ICRBC, ASC, edgeR, and DESeq on the Cumbie, Katz, and Bottomly datasets. Note
that these studies followed a mathematically averaged design, and no biologically averaged samples are
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available. Therefore, we ran ICRBC on either individual sample pairings between control and treatment
groups (“Singles”) or on gene-by-gene arithmetically averaged count tables of the control and treatment
count tables (“MA”). ASC was run exclusively on “MA” samples.
“Single” sample pairings can be interpreted as biologically averaged samples with only a single indi-
vidual enrolled, and thus provide a lower bound for the expected performance of ICRBC. By contrast,
“MA” runs provide an upper bound on the expected performance of ASC and ICRBC. This is because
gene-by-gene arithmetic averages of count tables are slightly better than perfectly pooled biologically
averaged samples as they are also averaging over technical variation. For the Cumbie and Katz datasets
all possible pairings between individual samples were considered since there were only three and two
biological replicates of each condition, respectively. Because the Bottomly dataset contained ten or more
biological replicates per condition, we randomly selected two from each for the “Singles” comparisons.
The top panels in Figure 5 illustrate how the expected FDR for each method behaves as more features
are called differently expressed. The expected FDR curve for ICRBC-MA is bounded by the FDR curves
of edgeR and DESeq, which tend to be liberal and conservative classifiers, respectively [34]. By contrast
the FDR curve for ASC-MA majorizes the DESeq curve, which may suggest it is being too conservative. In
the Katz and Bottomly datasets, both ICRBC-MA and ASC-MA FDR curves tend to lie above DESeq’s.
Taken together, this suggests that in an evenly pooled biologically averaged experiment, ICRBC and
ASC may tend to conservatively estimate the set of differentially expressed genes.
ICRBC-MA shows considerable concordance with edgeR (Figure 5, bottom). Both agree on 88%-
94% of the top 200 features in each dataset, and agreement stays above 83% for the top 1000 features.
While edgeR significance ordering may not be considered as ground truth, our simulation results and
edgeR’s usage of all sequenced samples, suggest it will be, on average, more accurate than ICRBC or
ASC. Therefore, ICRBC-MA’s agreement with edgeR implies that many of ICRBC’s detected features
are likely truly altered in expression.
However, these results must be taken in context of the variability and relatively higher discordance
of the “Singles” curves seen in the Cumbie and Katz datasets. Especially in the Cumbie dataset, the
“Singles” FDR and agreement curves illustrate the decreased reliability of highly uneven biological aver-
aging. Even in the Katz dataset where the “Singles” FDR curves lie in closer proximity to each other,
their agreement with edgeR decreases substantially as more features are called differentially expressed.
Interestingly, for the Bottomly dataset, agreement with edgeR for the top 100 loci is at least 87% for
all “Singles.” Together with the rapid increase in the “Singles” FDR curves around 200 features called,
this result suggests that the top 200-300 alternatively expressed loci in the Bottomly dataset may have
been extractable from just a few samples.
Discussion
If cost isn’t a limiting factor in experimental design, choosing a mathematically averaged design is ideal.
However, when biological variance is large and sequencing and library preparation costs exceed tissue
isolation costs, biological averaging may be more cost effective and still afford statistically tractable
data. This result is intuitively reasonable because biological averaging controls exclusively for biological
variation, and fewer samples are ultimately sequenced.
When, in addition, fewer than 20% of the regulome is expected to be differentially expressed one
may use ICRBC to analyze biologically averaged experiments. Because regulatory networks are sparse,
alteration of any non-essential pathway component will, in many cases, involve less than 10% of the
organism’s regulome [27]. Therefore, ICRBC’s 20% breakdown threshold is reasonable for many studies,
including the Cumbie, Katz, and Bottomly experiments examined here.
If 10 or more individuals are evenly pooled in a biologically averaged design, our simulation results
suggest that ICRBC may accurately detect 75% of differentially expressed feature at an FDR as low as
0.001. Obtaining 10-20 individuals is often experimentally reasonable and within the optimal range where
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biological averaging is expected to be statistically more cost efficient than mathematical averaging, even
if pooling is slightly uneven. Additionally, ICRBC’s concordance with edgeR remains above 95% for the
top 4160 features in simulation and above 88% for the top 400 features in the real datasets. In sum,
these observations imply that ICRBC can, with substantially fewer sequenced samples, uncover the top
few hundred differentially expressed loci in evenly pooled biologically averaged experiments that enroll a
reasonably high number of individuals.
Nevertheless, ICRBC’s and ASC’s subpar performance on unevenly pooled individuals in simulation
and their “Singles” performance in real data, clearly illustrate the potential pitfalls of highly uneven
pooling – low accuracy, and high variability. For biological averaging to be effective, care must be taken
when pooling tissue samples prior to library preparation.
Finally, ICRBC’s seemingly superior classification performance over ASC in simulation and greater
agreement with edgeR in real data is noteworthy. Both ICRBC and ASC qualitatively define differential
expression as unexpectedly large differences in log-expression given average expression; however, ASC
makes heavily parametric assumptions about the distribution expression values across loci. In order
to condition the null variance of log-expression difference on average expression, ASC assumes that
log10RPM expression across loci follows a shifted exponential distribution, a monotonically decreasing
distribution. Visual inspection of most histograms illustrating expression distributions across loci usually
reveals considerable bimodality (see Figure 1 in SI), and thus argues against using a shifted exponential
distribution.
ICRBC, by contrast, estimates the heteroscedastic variance function of log-expression difference using
a nonparametric LOESS smoothing procedure. Given most genomes and exomes have tens to hundreds
of thousands of loci, the nonparametric fitting is well supported and likely better captures regulome-wide
expression distributions, which may be heterogeneous across datasets.
Conclusion
When obtaining RNA-seq replicates is difficult, either due to cost or scale of study, biological averaging can
be a useful alternative to mathematical averaging. When high interpopulation similarity is suspected and
pooling evenness can be guaranteed, a biologically averaged experiment may be performed and analyzed
with our ICRBC method. Biological averaging and ICRBC are not meant to replace mathematical aver-
aging and associated analysis tools; however, biological averaging and subsequent analysis with ICRBC
can provide statistically reasonable results with less than half of the data previously required. This en-
ables biologists to enroll more individuals or, at the very least, perform reliable exploratory analyses for
a fraction of the cost.
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Figure 1. Schematic of a A) traditional mathematically averaged experiment, and B) a
biologically averaged one. Biological variation between individuals at a particular locus is denoted
by σ2B(g), and the technical variation associated with the measurement process is given by σ
2
T (g). For
biologically averaged experiments, the coefficients a1, . . . an denote the pooling proportions of the each
individual.
Tables
αˆ q s median depth
Cumbie 0.083 17 222 5,082,539
Katz 0.047 15 193 1,956,745
Bottomly 0.038 20 203 3,102,573
Table 1. Estimated ERCE parameters for the three real datasets. Here αˆ, q, and s denotes the
estimated dispersion parameter, tissue isolation cost, and sequencing cost, respectively. The median
depth is the sum of the median (exemplar) expression profile of counts.
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Figure 2. Empirical estimates of the ERCE function as a number of individuals for the
Cumbie, Katz, and Bottomly datasets. Mathematically averaged designs are naturally more
sensible than perfectly unevenly pooled biological ones; however, even for uniformly uneven pooling, the
estimated ERCE remains below 1 for the first twenty individuals, suggesting that biological averaging is
the more cost efficient design in these datasets.
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Figure 3. Overlayed MA plots of control (MgCl2) vs. control (blue) and control vs.
treatment (DC3000∆hrcC, red) samples from the Cumbie dataset. While the mean of M is
constant across A, considerable heteroscedasticity can be seen. In addition, near the superior edge the
cloud of red points extends beyond the cloud of blue points, suggesting the loci these red points
represent may be differentially expressed.
16
A	   B	  
C	  
D	  
E	  
One	  Sample	  Performance	   Breakdown	  Perf.	  
Two	  Sample	  Performance	  
Five	  Sample	  Performance	  
Ten	  Sample	  Performance	  
Figure 4. ‘Mathematical versus Biological Averaging’ and ‘Breakdown’ simulation study
results. A) Performance trends of ICRBC and ASC when only a single sample is available. Left: FDR
curves depicting the expected (dotted) and true (solid) FDR of each method as an increasing number of
genes are called differentially expressed. Middle: ROC curves illustrating classification accuracy. B)
‘Breakdown’ performance of each method as depicted by their classification accuracy as a function of
the percent of genes differentially expressed. Parts C-E) continue the ‘Mathematical versus Biological
Averaging’ simulation study results and show 2, 5 and 10 sample performance trends for each method,
respectively. As in A) the left and middle panels illustrate FDR and ROC curves, respectively. The
right panel illustrates agreement with edgeR as an increasing number of genes are called differentially
expressed. Here method x’s agreement with method y is defined to be |DEn(x) ∩DEn(y)| ÷ |DEn(y)|,
where DEn(a) denotes the set of differentially expressed genes for method a when n genes are called.
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Figure 5. Performance trends for the A) Cumbie, B) Katz, and C) Bottomly datasets.
FDR curves (top) illustrate the behavior of the expected FDR of each method as a function of the
number of genes called differentially expressed. Agreement plots (bottom) depict each methods
agreement with edgeR as defined for Figure 4.
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1 Relative Cost Efficiency
Let Xgi be the true expression level of gene g in individual i, and suppose that across individuals
each Xg,i are IID with some population level density fX(x). Recall that Oij denotes the observed
number of reads that map to loci i in individual j. Let the point estimate for the expression level
for gene g in a mathematically averaged experiment be dm(g,O), and the point estimate for a
biologically averaged experiment be db(g,O). Here O is the p-loci by n-individuals count matrix.
For a mathematically averaged experiment, the variance of dm(g,O) is given by,
V[dm(g,O)] = V
(
1
n
n∑
i=1
Ogi
)
=
1
n2
n∑
i=1
V(Ogi)
=
1
n2
n∑
i=1
(σ2T (g) + σ
2
B(g))
=
1
n
(σ2T (g) + σ
2
B(g))
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Likewise, for a biologically averaged experiment,
V[db(g,O)] = V(Og1) = σ
2
T (g) + V
(
n∑
i=1
aiXgi
)
= σ2T (g) +
n∑
i=1
a2iV(Xgi)
= σ2T (g) + σ
2
B(g)
n∑
i=1
a2i
= σ2T (g) + σ
2
B(g)
where
∑
ai = 1 and  =
∑
a2i .
The relative efficiency of these two procedures is computed as the ratio of their variances. Thus,
effrel(db, dm) =
V[db(g,O)]
V[dm(g,O)]
=
σ2T (g) + σ
2
B(g)
1
n(σ
2
T (g) + σ
2
B(g))
> 1
To calculate the relative cost efficiency, we multiply the relative efficiency by the procedural cost
ratio:
effrc(n|db, dm) = cost(db)
cost(dm)
× V[db(g,O)]
V[dm(g,O)]
=
nq + s
n(q + s)
× σ
2
T (g) + σ
2
B(g)e
1
n(σ
2
T (g) + σ
2
B(g))
=
nq + s
q + s
× σ
2
T (g) + σ
2
B(g)e
σ2T (g) + σ
2
B(g)
The function cost(di) gives the cost of the point estimate provided by measurment procedure i.
2 Expected Relative Cost Efficiency
After assuming that read counts follow a Negative-Binomial distribution, we found in the main
text that the expected relative cost efficiency was given by,
E[effrc(n, µ|db, dm)] =
(
nq + s
q + s
)∫
µ∈R+
µ+ αµ2
µ+ αµ2
f(µ) dµ.
To our knowledge we are not aware of a probability density function that describes the distribution
of expression levels for loci in a genome. We have noticed that often many, if not most, genes
have low levels of expression (fewer than 30 reads), while the remaining genes are expressed at
more detectable levels. Figure 1 illustrates the logarithm of the median expression distribution
of the control (wildtype) samples in each of the real datasets we considered in this paper. While
an exponential or zipf distribution could be used to describe the untransformed expression
distribution, its unclear to us why, mechanistically speaking, gene expression levels across loci
2
Figure 1: Log expression distributions of the Cumbie, Katz, and Bottomly datasets. These
histograms were made using 400 bins.
should necessarily follow an exponential decay pattern.
So without assigning a parametric family to f(·), the following algorithm may be used to empirically
estimate E[effrc(n, µ|db, dm)] given a RNA-Seq count matrix.
2.1 Empirical Estimation of the Expected Relative Cost Efficiency
1. Given a p-loci by n-individuals count matrix O, remove loci (rows) of O that do not have any
reads in any samples (0’s all the way across the table).
2. Generate 100 bootstrap replicate tables of O (subsample p rows of O with replacement 100
times to produce 100 “new” tables).
3. Run edgeR on each boostrap replicate table, and let the estimate of α be the average of
edgeR’s common.dispersion output statistic from each run. Call the bootstrapped estimate
of α, αˆ.1
4. Choose the number of individuals for which the expected relative cost efficiency should be
evaluated. Call this number k.
5. Select a pooling evenness:
• If perfectly even, set  to 1/n.
• If perfectly uneven, set  to 1.
• If uniformly uneven, generate a random vector, a, of uniform random numbers of length
k and divide a by its sum. Set  to
∑k
i=1 a
2
i . In the main text we generated multiple
uniformly uneven pooling weights so that we could visually assess the variance associated
with uniformly uneven pooling.
6. Set a tissue isolation cost q, and library preparation plus sequencing cost, s. We estimated
these costs from the methods reported in the Cumbie, Katz, and Bottomly papers with respect
1Though bootstrapping will give a stable estimate of α, in our experience the α estimated from each replicate
rarely varies by more than 5%. For computational ease, boostrapping can probably be skipped. Instead the original
table, O, may be used as an inpute to edgeR.
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Figure 2: Pooling types considered in ERCE estimation for the Cumbie, Katz, and Bottomly
datasets. Perfectly even and perfectly uneven pools represent the best and worst case, respectively.
Uniformly uneven pools are more likely to represent reality.
to today’s (September 5, 2013) prices. A table of our estimates are given in the main text,
and we provide a discussion of how we obtained these estimates in the next section.
7. Calculate the median expression profile to be the vector whos ith entry denotes the median
expression level of the ith loci across all samples within a particular population (e.g. all
wildtype samples).
8. Organize the loci in this median expression profile by expression level (counts) into B ordered
bins (just like the histogram in Figure 1, but untransformed). We arbitrarily set B to 400.
However, we get statistically indistinguishable results for 100 ≤ B ≤ 1000 (data not shown).
9. Let u(i) be the average expression level of all loci that fall into the ith smallest bin, and
let |B(i)| denote the number of loci that fall into the ith smallest bin. Nonparametrically
estimate the expected relative cost efficiency using the following formula,
E[effrc(k, µ|db, dm)] ≈
(
kq + s
q + s
) B∑
i=1
u(i) + αˆu(i)2
u(i) + αˆu(i)2
· |B(i)|
p
.
Pooling evenness, , was assumed to be either perfectly even, perfectly uneven, or uniformly uneven
(Figure 3). Uniformly uneven pooling weights for n individuals are obtained by generating an n-long
Uniform[0,1] random vector and normalizing it by its sum.
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2.2 Cost estimation for ERCE comparisons on the real datasets
Tissue isolation cost, q, involved the cost of TRIzol reagent (Invitrogen, Carlsbad CA), RNAlater
(Qiagen, Valencia CA), and system specific costs. We did not include the cost of RNA quantification
equipment (e.g. Agilent Bioanalyzer, Santa Clara, CA) in this assessment. The libarary preparation
and sequencing cost, s, was estimated using prices from the High Throughput Sequencing Facility
(https://sites.google.com/site/htsfunc/) at the University of North Carolina at Chapel Hill.
As of this writing, the price per library is $175.61 and a TCGA standard ( 165 million reads per lane
on an Illumina HiSeq 2500) RNA-Seq run is $1502.60. We assumed that the $175.61 was a fixed
cost per individual enrolled; however, we assumed that each individual’s library could be perfectly
multiplexed in a single lane with enough external samples such that only the desired depth for that
individual sample was obtained. Thus, to calculate the cost of obtaining another sequenced sample
at the median depth, d, obtained from each study, we used
s = 175.61 + d× 1502.6/(165× 106)︸ ︷︷ ︸
cost of a single sample at depth d
For example, Bottomly et al require scalpels and petri dishes (system specific costs $12), and
TRIzol reagent and RNA later ( $8 for just the volume they report they use). Together, their
tissue isolation cost was therefore q = 20 dollars. The median read depth in the Bottomly study
was 3,102,573. Thus, their library preparation and sequencing cost, s, amounts to 175.61+1956745×
1502.6/(165× 106) ≈ 203.
3 Approximate normality of M given A
Let O1 and O2 denote the observed counts of a given gene in two different samples. Assume that
O1 and O2 are independent. Let p1 and p2 denote the true probability a read will map to this gene
in each respective sample, and let n1 and n2 denote the total number of reads in each respective
sample. The Random Sampling model for RNA seq asserts that the sequencing process samples
completely at random a limited amount of all of the total transcript available in a tissue. This
can be seen (and has been shown ref) as a binomial experiment, such that Oi ∼ Binomial(ni, pi).
Given that ni is typically large and pi is typically small (since there are many genes), it is often
assumed (to good approximation) that, Oi ∼ Poisson(µi), where µi = nipi.
The Random Sampling model has been use satisfactorily to describe technical variation; however,
the Poisson assumption cannot adequately account for biological variation. The Negative Binomial
2 (NB2) model is a generalization of the Poisson model, and is capable of handling overdispersion.
As a Poisson-Gamma mixture model, the NB2 distribution has expected value and variance given
by E[X] = µ = np and V[X] = µ + αµ2 = np + α(np)2, where n and p are the parameters of the
underlying binomial process, and α is the dispersion parameter measuring the extent of biological
variation.
We assume that Oi ∼ NB2(µi, α). Let Ki = log(Oi), and define M = K1−K2 and A = (K1+K2)/2.
To show that the conditional distribution of M given A is normally distributed, we must first show
that each Ki are asymptotically normally distributed. Our proof closely follows (DEGseq SI ref).
As n1 and n2 grow large, as is typical for a sequencing experiment, the asymptotic distribution of
Oi/ni is given by,
√
ni
(
Oi
ni
− pi
)
D→ N (0, p+ αnp2)
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We can equivalently write this as,
√
ni (Oi − µi) D→ N (0, µi + αµ2i )
Using Delta Method, we can obtain the asymptotic distribution (as ni →∞) of Ki as follows,
√
ni(Ki − log(µi)) = √ni(log(Oi)− log(µi))
D→ N
(
0, (µi + αµ
2
i )
[
∂
∂µi
log(µi)
]2)
= N
(
0,
1 + αµi
µi
)
Therefore we have,
Ki
D→ N
(
log(µi),
1 + αµi
niµi
)
At this point we have shown that Ki is approximately normally distributed for large ni. For
convenience let τi = log(µi) and σ
2
i = (1 + αµi)/(niµi). Given that O1 and O2 are independent,
K1 and K2 will be independent. Therefore, we have
M ∼ N (τ1 − τ2, σ21 + σ22) = N (τM , σ2M)
A ∼ N
(
1
2
(τ1 + τ2),
1
4
(σ21 + σ
2
2)
)
= N (τA, σ2A)
Finally, the conditional distribution of a normal random variable given another is also a normal
random variable (ref). So, the conditional distribution of M given A = a is,
M |A=a ∼ N
(
τM + ρ
σM
σA
(a− τA), σ2M (1− ρ2)
)
Here ρ is the correlation coefficient between M and A.
3.1 Invariance of the mean of M
The expected value is invariant with respect to A under the null distribution that p1 = p2 = p.
E[M ] = τ1 − τ2
= log(µ1)− log(µ2)
= log(n1p1)− log(n2p2)
= log(n1p)− log(n2p) (under nullity)
= log(n1)− log(n2)
This final expression depends only on the sequencing depths of the two samples, which are both
known at the time of analysis. Thus, the mean of M does not depend on A.
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Figure 3: Pooling weights for simulated ‘normal’ and ‘abnormal’ individuals in the ‘Biological
versus Mathematical Averaging’ and ‘Breakdown’ simulation studies.
3.2 Heteroscedasticity with respect to A
To clearly see the heteroskedastic dependence of the variance of M on A,
σ2M = σ
2
1 + σ
2
2
=
1 + αµ1
n1µ1
+
1 + αµ2
n2µ2
=
n2µ2 + n1µ1 + µ1µ2α(n1 + n2)
n1n2µ1µ2
=
n2µ2 + n1µ1 + exp {(log(µ1) + log(µ2)}α(n1 + n2)
n1n2 exp {(log(µ1) + log(µ2)}
=
n2µ2 + n1µ1 + exp {E[K1] + E[K2]}α(n1 + n2)
n1n2 exp {E[K1] + E[K2]}
=
n2µ2 + n1µ1 + exp {E[K1 +K2]}α(n1 + n2)
n1n2 exp {E[K1 +K2]}
=
n2µ2 + n1µ1 + exp {2E[A]}α(n1 + n2)
n1n2 exp {2E[A]}
In an MA plot we can visually see that the variance of M decreases in increasing A. Does the
above expression agree with this intuition? To answer this, it will be sufficient to show that the
derivative of σ2M with respect to A is negative,
∂σ2M
∂A
= −2 exp(−2E[A])(µ1n1 + µ2n2)
n1n2
Af(A)
where f(A) is the exact density of A. This expression is in fact negative, which agrees with our
intuition.
4 Pooling weights for the simulation study
In the ‘Biological versus Mathematical Averaging’ and ‘Breakdown’ simulation studies, we
considered even or uneven transcript vector pools. For uneven pooling, we wanted to consider a
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more uneven pool than is likely to occur in practice.
Figure 3 illustrates the pooling weights for individuals that were unevenly pooled. When consid-
ering uneven pooling weights for an n sample performance comparison in the ‘Biological versus
Mathematical Averaging’ experiment, the first n pooling weights in each treatment group (‘Nor-
mal’ and ‘Abnormal’), were taken and divided by their sum. Notice that the first individual in
‘Normal’ and ‘Abnormal’ samples always represented more than 40% of the pool.
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